Target intelligence / Profile preview

Potassium-transporting ATPase subunit beta (ATP4B) (ATP4B)

Target
ATP4B
Molecular classification
Transporter, Enzyme, P-type ATPase
01

Overview

The Gastric H+/K+-ATPase beta subunit (ATP4B) is a type II transmembrane glycoprotein that serves as the essential accessory subunit for the gastric proton pump (UniProt: P51164). It plays a critical role in the maturation, stable assembly, and apical membrane targeting of the catalytic alpha subunit (ATP4A) within gastric parietal cells (PubMed: 10913254). The functional holoenzyme is responsible for the final step of gastric acid secretion, transporting protons into the stomach lumen in exchange for potassium ions via ATP hydrolysis (StatPearls: NBK546650). Clinical targeting of this enzyme complex is the gold standard for treating acid-related disorders, including gastroesophageal reflux disease (GERD) and peptic ulcers (PubMed: 26307015). While drugs like proton pump inhibitors (PPIs) and potassium-competitive acid blockers (P-CABs) primarily target the alpha subunit's catalytic cycle, the beta subunit is indispensable for the pump's structural integrity and overall acid-secreting capacity (PubMed: 11566453). Notably, the beta subunit is a major autoantigen in autoimmune gastritis and pernicious anemia, where autoantibodies against the subunit lead to parietal cell destruction and vitamin B12 malabsorption (PubMed: 15273414).

Other names
Gastric H+/K+ ATPase beta subunitATP4BProton pump beta subunitH-K-ATPase beta subunitPotassium-transporting ATPase subunit betaATPase H+/K+ transporting subunit beta
02

Mechanism of action

Inhibition of the gastric H+/K+-ATPase enzyme complex, which prevents the exchange of intracellular H+ for extracellular K+, thereby halting the final step of gastric acid production.

03

Biological functions

Gastric acid secretionIon transportProtein folding and traffickingStructural stabilization
04

Disease associations

Gastroesophageal reflux diseasePeptic ulcer diseaseZollinger-Ellison syndromeGastritisAutoimmune gastritisPernicious anemia
05

Safety considerations

HypomagnesemiaVitamin B12 deficiencyIncreased risk of Clostridioides difficile infectionBone fracturesHypergastrinemia
06

Interacting drugs

Omeprazole

7 more in the full profile.

07

Biomarkers

Intragastric pHSerum gastrinChromogranin AAnti-parietal cell antibodies

Beyond the preview

Go deeper on Potassium-transporting ATPase subunit beta (ATP4B) (ATP4B).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Potassium-transporting ATPase subunit beta (ATP4B) (ATP4B).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call